Results 141 to 150 of about 204,330 (266)

The Role of Drug Resistance in Candida Inflammation and Fitness

Microorganisms
Drug resistance in Candida may result in either a fitness cost or a fitness advantage. Candida auris, whose intrinsic drug resistance remains unclear, has emerged as a significant human pathogen. We aimed to investigate whether Candida fitness, including
Gabriella Piatti, Alberto Vitale, Anna Maria Schito, Susanna Penco, Daniele Saverino   +4 more
doaj   +1 more source

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis. [PDF]

, 2019
Invasive pulmonary aspergillosis (IPA) due to Aspergillus fumigatus is a serious fungal infection in the immunosuppressed patient population. Despite the introduction of new antifungal agents, mortality rates remain high, and new treatments are needed ...
Alkhazraji, Sondus, Alqarihi, Abdullah, Gebremariam, Teclegiorgis, Gu, Yiyou, Ibrahim, Ashraf S, Jeon, Heewon H, Kapoor, Mili, Shaw, Karen J   +7 more
core  

بررسی تاثير ترکيب نيستاتين و فلوکونازول با ماده بهسازی بافت بر وضعيت کلونيزاسيون کانديدا آلبيکنس [PDF]

, 2014
خلاصه: سابقه و هـدف: هرچند استفاده از لايه نازک ماده بهسازی بافت برای کنترل ضايعه دنچر استوماتيت به کار می رود ولی اين ماده زمينه مناسب برای کلونيزاسيون کانديدا فراهم می‌آوردکه با ترکيب داروهای ضدقارچی ميتوان آن راکنترل نمود.
تفتی, فلاح, جعفری, عباسعلی, عشوری, حسن, میرزایی پور, لیلا   +3 more
core  

FIRST CASES IN BULGARIA WITH PROVEN CANDIDA AURIS IN IMMUNOCOMPROMISED PATIENTS

Problems of Infectious and Parasitic Diseases
Candida auris is a fungus with pathogenic potential, first isolated in 2009 in Japan. Since then, sporadic cases have been reported, which have increased significantly in recent years.
Lyubomira Boyanova, Zoya Ivanova, Asya Bachvarova   +2 more
doaj   +1 more source

Clin Microbiol Newsl [PDF]

| is a newly emerging species that was first identified in Asia in 2009 but has rapidly spread across the world.|differs from most other|species in that antifungal resistance is the norm rather than the exception, it is a commensal of human skin rather ...

core  

Epi Update for Friday, August 18, 2017 [PDF]

, 2017
Weekly Newsletter for the Center for Acute Disease Epidemiology of the Iowa Department of Public ...

core  

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Clinical Infectious Diseases, 2017
S. Lockhart, Kizee A. Etienne, S. Vallabhaneni, J. Farooqi, A. Chowdhary, N. Govender, A. Colombo, B. Calvo, Christina A. Cuomo, C. Desjardins, E. Berkow, M. Castanheira, R. Magobo, K. Jabeen, R. Asghar, J. Meis, Brendan R. Jackson, T. Chiller, A. Litvintseva   +18 more
semanticscholar   +1 more source

Relationships Between Candida auris and the Rest of the Candida World—Analysis of Dual-Species Biofilms and Infections

Pathogens
In this study, we investigated the interactions between Candida auris and C. albicans, C. tropicalis, C. glabrata, and C. krusei in mixed infections. Initially, these interactions were studied qualitatively and quantitatively in dual-species biofilms ...
Monika Janeczko, Tomasz Skrzypek
doaj   +1 more source

Pathogenesis, Prophylaxis, and Treatment of Candida auris

Biomedicines
Candida auris poses a serious threat to infection control and patient care since it can produce invasive infections that have a high fatality rate, has been linked to outbreaks in hospital environments, and is typically resistant to several antifungal ...

semanticscholar   +1 more source

Evolutionary accumulation of FKS1 mutations from clinical echinocandin-resistant Candida auris

Emerging Microbes and Infections
Introduction: Drug resistance to echinocandins, first-line drugs used to treat Candida auris infection, is rapidly emerging. However, the accumulation of mutations in genes other than FKS1 (before an isolate develops to resistance via FKS1 mutations ...
Sufei Tian, Yusheng Wu, Hailong Li, Chen Rong, Na Wu, Y. Chu, Ning Jiang, Jingping Zhang, Hong Shang   +8 more
semanticscholar   +1 more source